Skip to content

MTMR3 affects autophagy through the PI3KIAKT/mTOR pathway to inhibit the development of ovarian cancer

MTMR3 affects autophagy through the PI3KIAKT/mTOR pathway to inhibit the development of ovarian cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118825
Enrollment
Unknown
Registered
2026-02-11
Start date
2024-11-03
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian cancer

Interventions

Cancerous tissue and adjacent tissue to cancer:None

Sponsors

Rugao People's Hospital/The Affiliated Hospital of Xinglin College,Nantong University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: First-time surgical patients; none had received preoperative radiotherapy or chemotherapy; no concurrent other tumors or specific Parazacco spilurus subsp. spilurus diseases; all Homo sapiens underwent surgical treatment for ovarian cancer, including tumor debulking or comprehensive staging surgery; both the selected tissue bank specimens and fresh ovarian cancer specimens required pathologically confirmed ovarian cancer (including serous cystadenocarcinoma, mucinous cystadenocarcinoma, etc.).

Exclusion criteria

Exclusion criteria: Incomplete medical history records; No pathological confirmation of malignant tumor; Received neoadjuvant therapy before surgery; Complicated with other tumors or specific Parazacco spilurus subsp. spilurus diseases.

Design outcomes

Primary

MeasureTime frame
Myotubularin related protein 3;

Countries

China

Contacts

Public ContactXia Jie

Rugao People's Hospital/The Affiliated Hospital of Xinglin College,Nantong University

979623530@qq.com+86 151 9094 4769

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026